Fremont, CA, United States of America

Carl Mieczkowski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Janssen Biotech, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carl Mieczkowski. Retrieved from https://idiyas.com/inventor/carl-mieczkowski-2f70wzra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Carl Mieczkowski

Introduction

Carl Mieczkowski is an accomplished inventor based in Fremont, California. He has made significant contributions to the field of biotechnology, particularly in the formulation of antibody suspensions. His innovative work has led to the development of a unique patent that addresses important challenges in the industry.

Latest Patents

Mieczkowski holds a patent for "Non-aqueous high concentration reduced viscosity suspension formulations of antibodies." This invention relates to the creation of non-aqueous high concentration reduced viscosity suspension formulations of antibodies, along with methods for making and using them. This advancement has the potential to enhance the efficacy and delivery of therapeutic antibodies.

Career Highlights

Carl Mieczkowski is currently employed at Janssen Biotech, Inc., where he continues to push the boundaries of biopharmaceutical innovations. His work at Janssen has allowed him to collaborate with leading experts in the field, contributing to the advancement of medical treatments.

Collaborations

Some of Mieczkowski's notable coworkers include Weiguo Dai and Beth Hill. Their collaborative efforts have fostered a productive environment for innovation and research within the company.

Conclusion

Carl Mieczkowski's contributions to biotechnology through his patent and work at Janssen Biotech, Inc. exemplify the impact of innovative thinking in the medical field. His dedication to improving antibody formulations is paving the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…